Seoul, South Korea · Founded 2020 · Privately Held (backing)
Developer of molecular design technology designed to develop novel drugs against attractive targets. Galux is based in Seoul, South Korea and was founded in 2020. Its last reported valuation was $67.8 million in Oct 2022. It has raised $32.4 million.
Last reported valuation
$67.8M
Oct 2026
Priced at
—
Total raised
$32.4M
Last round
—
Cap table — not yet on record
Galux's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Galux with a free account
·The complete investor list: 20 names
·Watch Galux: the Monday email on marks, rounds and moves
